✦ LIBER ✦

Repetitive high-dose therapy with cyclophosphamide, thiotepa and docetaxel with peripheral blood progenitor cell and filgrastim support for metastatic and locally advanced breast cancer: results of a phase I study

✍ Scribed by Prince, H M; Rischin, D; Toner, G C; Seymour, J F; Blakey, D; Gates, P; Eerhard, S; Chapple, P; Quinn, M; Brettell, M

Book ID: 110012815
Publisher: Nature Publishing Group
Year: 2000
Tongue: English
Weight: 78 KB
Volume: 26
Category: Article
ISSN: 0007-1188
DOI: 10.1038/sj.bmt.1702650

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Repetitive high-dose therapy with periph

Repetitive high-dose therapy with peripheral blood progenitor cell (PBPC) support for metastatic (MBC) and locally advanced breast cancer

📂 Article 📅 2000 🏛 Nature Publishing Group 🌐 English ⚖ 244 KB

Phase II trial of sequential high-dose c

Phase II trial of sequential high-dose chemotherapy with paclitaxel, melphalan and cyclophosphamide, thiotepa and carboplatin with peripheral blood progenitor support in women with responding metastatic breast cancer

✍ Vahdat, L T; Balmaceda, C; Papadopoulos, K; Frederick, D; Donovan, D; Sharpe, E; 📂 Article 📅 2002 🏛 Nature Publishing Group 🌐 English ⚖ 108 KB

A phase I/II study of high-dose cyclopho

A phase I/II study of high-dose cyclophosphamide, cisplatin, and thioTEPA followed by autologous bone marrow and granulocyte colony-stimulating factor-primed peripheral-blood progenitor cells in patients with advanced malignancies

✍ A. M. Hussein; William P. Petros; Maureen Ross; James J. Vredenburgh; Mary Lou A 📂 Article 📅 1996 🏛 Springer 🌐 English ⚖ 300 KB

A phase I–II study of high-dose melphala

A phase I–II study of high-dose melphalan, mitoxantrone and carboplatin with peripheral blood stem cell support in patients with advanced ovarian or breast carcinoma

✍ Weaver, C H; Greco, F A; Hainsworth, J D; Zhen, B; Baldwin, P; Wittlin, F; Lewis 📂 Article 📅 1997 🏛 Nature Publishing Group 🌐 English ⚖ 89 KB

A phase I/II study of sequential, dose-e

A phase I/II study of sequential, dose-escalated, high dose ifosfamide plus doxorubicin with peripheral blood stem cell support for the treatment of patients with advanced soft tissue sarcomas

✍ Carsten Bokemeyer; Anke Franzke; Jörg T. Hartmann; Christoph Schöber; Lubomir Ar 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 85 KB 👁 2 views

ide combined with full dose doxorubicin chemotherapy supported with peripheral blood stem cells (PBSC) and granulocyte-colony stimulating factor (G-CSF) in

A randomized phase III comparative trial

A randomized phase III comparative trial of immediate consolidation with high-dose chemotherapy and autologous peripheral blood progenitor cell support compared to observation with delayed consolidation in women with metastatic breast cancer and only bone metastases following intensive induction chemotherapy

✍ Vredenburgh, J J; Madan, B; Coniglio, D; Ross, M; Broadwater, G; Niedzwiecki, D; 📂 Article 📅 2006 🏛 Nature Publishing Group 🌐 English ⚖ 141 KB